ibrutinib

AbbVie's stock falls after lymphoma treatment trial data disappoints
Marketwatch
Wed, 07/11/18 - 10:19 am
AbbVie
ibrutinib
clinical trials
lymphoma
Pharmacyclics' Lymphoma Drug Receives FDA Approval
TheStreet.com
Wed, 11/13/13 - 12:50 pm
Pharmacyclics
FDA
Imbruvica
mantle cell lymphoma
ibrutinib
Cleveland Clinic picks top 3 blockbuster drug candidates in the late-stage pipeline
Fierce Biotech
Thu, 10/17/13 - 06:18 pm
Cleveland Clinic
JNJ
Pharmacyclics
Novartis
serelaxin
ibrutinib
sofosbuvir
Gilead
Pharmacyclics' Ibrutinib Could Crown Its Turnaround Story
Investors.com
Tue, 10/15/13 - 08:55 am
Pharmacyclics
ibrutinib
7 Disruptive Drugs for the Next Decade
Motley Fool
Wed, 10/9/13 - 10:42 pm
Tecfidera
Biogen Idec
Bristol-Myers Squibb
Eliquis
Pfizer
Roche
Kadcyla
Immunogen
sofosbuvir
Gilead
ibrutinib
Pharmacyclics
Sarepta
eteplirsen
LX4211
Lexicon Pharmaceuticals
[video]Cramer: Biggest blockbuster drug in ages?
CNBC
Sat, 09/28/13 - 12:18 pm
Pharmacyclics
ibrutinib
Rough market day for Nektar, while Pharmacyclics and Regeneron soar
Marketwatch
Fri, 09/27/13 - 08:37 am
Nektar
Pharmacyclics
Regeneron
osteoarthritis
NKTR-181
ibrutinib
Is the Tide About to Turn in the Fight Against Chronic Lymphocytic Leukemia?
Motley Fool
Wed, 09/18/13 - 10:34 am
chronic lymphocytic leukemia
Sanofi
Campath
GSK
Arzerra
Roche
Rituxan
ibrutinib
Pharmacyclics
obinutuzumab
JNJ
Genmab
These 2 Companies Are the Biggest Winners of the FDA's Breakthrough Designation
Motley Fool
Tue, 09/3/13 - 09:33 am
FDA
breakthrough therapies
ibrutinib
Pharmacyclics
JNJ
Novartis
LDK378
serelaxin
daratumumab
Genmab
FDA grants priority review to blood cancer treatment from Pharmacyclics
Yahoo/AP
Thu, 08/29/13 - 09:07 am
FDA
Pharmacyclics
Janssen
JNJ
ibrutinib
mantle cell lymphoma
chronic lymphocytic leukemia
What Does The FDA's Breakthrough Designation Mean For Investors?
Seeking Alpha
Mon, 08/26/13 - 01:28 pm
FDA
breakthrough therapies
AbbVie
Alexion
Ariad Pharmaceuticals
Biomarin
Bristol-Myers Squibb
SynaGeva BioPharma
GSK
JNJ
Merck
Novartis
Pharmacyclics
Pfizer
Vertex Pharmaceuticals
daratumumab
ibrutinib
Kalydeco
lambrolizumab
palbociclib
LDK378
SD-101
obinutuzumab
serelaxin
asfotase alfa
bimagrumab
drisapersen
sebelipase alfa
Johnson & Johnson's 3 Most Promising Drugs (video)
Motley Fool
Sat, 08/24/13 - 12:01 pm
Zytiga
Pharmacyclics
JNJ
Invokana
ibrutinib
This Small Company Is Winning the War Against Blood Cancer
Motley Fool
Wed, 08/21/13 - 06:59 pm
Pharmacyclics
mantle cell lymphoma
small lymphocytic lymphoma
chronic lymphocytic leukemia
ibrutinib
Expedited Drug Approval May Push Up Pharmacyclics' Value And Stock Price
Seeking Alpha
Mon, 08/12/13 - 05:03 pm
Pharmacyclics
ibrutinib
JNJ
chronic lymphocytic leukemia
mantle cell lymphoma
Breakthrough Status May Spur J&J Drug to Market Early
Bloomberg
Thu, 07/25/13 - 10:42 am
JNJ
breakthrough therapies
ibrutinib
Pharmacyclics
chronic lymphocytic leukemia
mantle cell lymphoma
A Developing "Breakthrough" In Biotechnology that You Should Monitor
Motley Fool
Sat, 07/13/13 - 12:31 pm
Pharmacyclics
ibrutinib
blood cancer
JNJ
AbbVie
Will This Be the Breakthrough of All Breakthrough Therapy Drugs?
Motley Fool
Thu, 07/11/13 - 11:09 am
breakthrough therapies
ibrutinib
Pharmacyclics
JNJ
chronic lymphocytic leukemia
Pharmacyclics and Johnson & Johnson submit blood cancer drug ibrutinib to FDA for approval
Yahoo/AP
Wed, 07/10/13 - 11:05 am
JNJ
Pharmacyclics
ibrutinib
chronic lymphocytic leukemia
[video]3 Blood Cancer Drug Hopefuls in the Spotlight
Motley Fool
Thu, 06/20/13 - 07:46 am
Infinity Pharmaceuticals
JNJ
Pharmacyclics
Gilead
non-Hodgkin's lymphoma
ibrutinib
Idelalisib
IPI-145
Making The Call: Pharmacyclics FDA Drug Approval Before Year End
TheStreet.com
Wed, 05/29/13 - 08:18 am
FDA
Pharmacyclics
JNJ
ibrutinib
B-cell cancers

Pages